Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (391-400 of 646) with videos related to

Pageof 65
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|March 10, 2021
Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum SupernatantFrauke Pedersen, Frederik Trinkmann, Mustafa Abdo, et al.
Pulmonary Pharmacology & Therapeutics|July 16, 2005
Markers of disease severity in chronic obstructive pulmonary diseaseLuigi G Franciosi, Clive P Page, Bartolome R Celli, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 22, 2001
Image analysis and quantification in lung tissueW I De Boer, P S Hiemstra, J K Sont, et al.
Cytokine|December 4, 2014
Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processingFrauke Pedersen, Olaf Holz, Gereon Lauer, et al.
Respiratory Medicine|September 1, 2015
Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patientsFrauke Pedersen, Sebastian Marwitz, Olaf Holz, et al.
Proceedings of the American Thoracic Society|December 21, 2012
How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop reportLeonardo M Fabbri, Cynthia Boyd, Piera Boschetto, et al.
Respiratory Research|May 12, 2006
Markers of exacerbation severity in chronic obstructive pulmonary diseaseLuigi G Franciosi, Clive P Page, Bartolome R Celli, et al.
Allergy|May 19, 2022
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinationsMarek Lommatzsch, Hendrik Suhling, Stephanie Korn, et al.
The American Journal of Physiology|April 1, 1996
Eosinophil VLA-4 binding to fibronectin augments bronchial narrowing through 5-lipoxygenase activationN M Muñoz, K F Rabe, S P Neeley, et al.
BMC Pulmonary Medicine|July 27, 2017
Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosisThomas Bahmer, Anne-Marie Kirsten, Benjamin Waschki, et al.
Pageof 65

Showing results (391-400 of 646) with videos related to

Sort By:
Pageof 65
International Journal of Chronic Obstructive Pulmonary Disease|March 10, 2021
Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum SupernatantFrauke Pedersen, Frederik Trinkmann, Mustafa Abdo, et al.
Pulmonary Pharmacology & Therapeutics|July 16, 2005
Markers of disease severity in chronic obstructive pulmonary diseaseLuigi G Franciosi, Clive P Page, Bartolome R Celli, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 22, 2001
Image analysis and quantification in lung tissueW I De Boer, P S Hiemstra, J K Sont, et al.
Cytokine|December 4, 2014
Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processingFrauke Pedersen, Olaf Holz, Gereon Lauer, et al.
Respiratory Medicine|September 1, 2015
Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patientsFrauke Pedersen, Sebastian Marwitz, Olaf Holz, et al.
Proceedings of the American Thoracic Society|December 21, 2012
How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop reportLeonardo M Fabbri, Cynthia Boyd, Piera Boschetto, et al.
Respiratory Research|May 12, 2006
Markers of exacerbation severity in chronic obstructive pulmonary diseaseLuigi G Franciosi, Clive P Page, Bartolome R Celli, et al.
Allergy|May 19, 2022
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinationsMarek Lommatzsch, Hendrik Suhling, Stephanie Korn, et al.
The American Journal of Physiology|April 1, 1996
Eosinophil VLA-4 binding to fibronectin augments bronchial narrowing through 5-lipoxygenase activationN M Muñoz, K F Rabe, S P Neeley, et al.
BMC Pulmonary Medicine|July 27, 2017
Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosisThomas Bahmer, Anne-Marie Kirsten, Benjamin Waschki, et al.
Pageof 65